文献速递贫血与红细胞疾病MDS 与骨髓增殖性肿瘤

血红素调节的eIF2α激酶在红细胞生成与血红蛋白病中的作用

Heme-regulated eIF2α kinase in erythropoiesis and hemoglobinopathies.
PubMed 文献 · Blood · 2019-01-01

该综述阐述血红素调节的eIF2α激酶(HRI)感知细胞内血红素浓度,通过eIF2α磷酸化整合应激反应(ISR)协调珠蛋白翻译与血红素可用性,并抑制mTORC1信号以反馈调节红细胞生成。HRI-ISR在铁/血红素缺乏时维持蛋白质稳态与线粒体功能,在β-地中海贫血小鼠模型中减轻病情,并参与人胎儿血红蛋白生成调控,成为血红蛋白病的潜在治疗靶点。

要点

  • HRI通过eIF2αP同时抑制珠蛋白mRNA翻译并选择性增强ATF4翻译,协调血红素与珠蛋白合成。
  • HRI-eIF2αP-ATF4通路抑制红系mTORC1信号,作为铁/血红素缺乏时促红细胞生成素刺激红细胞生成的反馈机制。
  • HRI-ISR在β-地中海贫血小鼠模型中激活以减轻中间型病情,并参与人胎儿血红蛋白生成调控。

核心结论

  • HRI-ISR通过协调ISR与mTORC1两条信号通路调控红细胞生成,避免无效红细胞生成,是血红蛋白病的潜在治疗靶点。

研究设计与样本

  • 本文为综述,总结HRI在红细胞生成与血红蛋白病中的信号机制及临床前研究证据。

主要发现

  • 铁/血红素缺乏时HRI激活使eIF2α磷酸化,同时抑制珠蛋白mRNA翻译并选择性增强ATF4 mRNA翻译以诱导应激反应基因。
  • HRI-eIF2αP在红系祖细胞中抑制一般蛋白质合成,防止蛋白质毒性并维持细胞质与线粒体蛋白质稳态。
  • HRI-eIF2αP-ATF4通路在铁/血红素缺乏时抑制红系mTORC1信号,作为促红细胞生成素刺激红细胞生成的反馈机制。
  • ATF4靶基因在铁缺乏时高度激活,以维持线粒体功能与氧化还原稳态并支持红系分化。
  • HRI-ISR在Hbbth1/th1小鼠模型中激活以减轻β-地中海贫血中间型病情,并参与人胎儿血红蛋白生成调控。

临床怎么用

  • HRI-ISR可作为血红蛋白病治疗靶点,通过调节珠蛋白翻译与红细胞生成改善无效红细胞生成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As essential components of hemoglobin, iron and heme play central roles in terminal erythropoiesis. The impairment of this process in iron/heme deficiency results in microcytic hypochromic anemia, the most prevalent anemia globally. Heme-regulated eIF2α kinase, also known as heme-regulated inhibitor (HRI), is a key heme-binding protein that senses intracellular heme concentrations to balance globin protein synthesis with the amount of heme available for hemoglobin production. HRI is activated during heme deficiency to phosphorylate eIF2α (eIF2αP), which simultaneously inhibits the translation of globin messenger RNAs (mRNAs) and selectively enhances the translation of activating transcription factor 4 (ATF4) mRNA to induce stress response genes. This coordinated translational regulation is a universal hallmark across the eIF2α kinase family under various stress conditions and is termed the integrated stress response (ISR). Inhibition of general protein synthesis by HRI-eIF2αP in erythroblasts is necessary to prevent proteotoxicity and maintain protein homeostasis in the cytoplasm and mitochondria. Additionally, the HRI-eIF2αP-ATF4 pathway represses mechanistic target of rapamycin complex 1 (mTORC1) signaling, specifically in the erythroid lineage as a feedback mechanism of erythropoietin-stimulated erythropoiesis during iron/heme deficiency. Furthermore, ATF4 target genes are most highly activated during iron deficiency to maintain mitochondrial function and redox homeostasis, as well as to enable erythroid differentiation. Thus, heme and translation regulate erythropoiesis through 2 key signaling pathways, ISR and mTORC1, which are coordinated by HRI to circumvent ineffective erythropoiesis (IE). HRI-ISR is also activated to reduce the severity of β-thalassemia intermedia in the Hbbth1/th1 murine model. Recently, HRI has been implicated in the regulation of human fetal hemoglobin production. Therefore, HRI-ISR has emerged as a potential therapeutic target for hemoglobinopathies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Chen JJ, Zhang S. Heme-regulated eIF2α kinase in erythropoiesis and hemoglobinopathies. Blood. 2019. PMID: 31554636. doi:10.1182/blood.2019001915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。